ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 141,46
-0,67%
Dow Jones
39 882,60
0,19%
DAX
18 726,76
-0,21%
Brent Oil
82,715
-0,98%
Bitcoin
69 363,40
-2,92%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Windtree Therapeutics Inc (WINT)

  7. Windtree Therapeutics Inc (WINT) Actualités

WINT

Windtree Therapeutics (WINT)

Windtree Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:WINT
DateHeureSourceTitreSymboleSociété
15/05/202422h59Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:WINTWindtree Therapeutics Inc
09/05/202414h41Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:WINTWindtree Therapeutics Inc
07/05/202414h00GlobeNewswire Inc.Windtree Therapeutics Regains Compliance with NasdaqNASDAQ:WINTWindtree Therapeutics Inc
18/04/202414h00GlobeNewswire Inc.Windtree Therapeutics Announces Reverse Stock SplitNASDAQ:WINTWindtree Therapeutics Inc
17/04/202414h00GlobeNewswire Inc.Windtree Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Key Business UpdatesNASDAQ:WINTWindtree Therapeutics Inc
08/04/202422h48GlobeNewswire Inc.Windtree Acquires Early-Stage, Novel Oncology Platform and Completes $1.5 Million Convertible Note Bridge FinancingNASDAQ:WINTWindtree Therapeutics Inc
16/02/202423h07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:WINTWindtree Therapeutics Inc
14/02/202423h23Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:WINTWindtree Therapeutics Inc
14/02/202422h30Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:WINTWindtree Therapeutics Inc
12/02/202422h40Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:WINTWindtree Therapeutics Inc
01/02/202423h26Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:WINTWindtree Therapeutics Inc
01/02/202414h00GlobeNewswire Inc.Windtree Renews Agreement with Chang Gung University for Scientific Collaboration to Further SERCA2a ResearchNASDAQ:WINTWindtree Therapeutics Inc
31/01/202414h40InvestorsHub NewsWireWindtree Therapeutics Announces Engagement of Strategic Advisor to Support Assessment of Strategic AlternativesNASDAQ:WINTWindtree Therapeutics Inc
25/01/202415h04InvestorsHub NewsWireWindtree Eliminates $15 Million Contingent Liability to Deerfield Management CompanyNASDAQ:WINTWindtree Therapeutics Inc
17/01/202414h00GlobeNewswire Inc.Windtree Therapeutics Announces License Agreement with Lee’s Pharmaceuticals to Develop and Commercialize Istaroxime, Dual Mechanism SERCA2a Activators and Rostafuroxin for Greater China / Asia Pacific RegionNASDAQ:WINTWindtree Therapeutics Inc
16/01/202422h16Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:WINTWindtree Therapeutics Inc
02/01/202422h05GlobeNewswire Inc.Windtree Therapeutics Announces Reduction In Arrythmias In A New Study With Istaroxime And A Pure SERCA2a ActivatorNASDAQ:WINTWindtree Therapeutics Inc
18/12/202314h00GlobeNewswire Inc.Windtree Therapeutics Announces the Start of Patient Dosing In Phase 2 SEISMiC Extension Study of Istaroxime in Early Cardiogenic ShockNASDAQ:WINTWindtree Therapeutics Inc
16/11/202314h00GlobeNewswire Inc.Windtree Therapeutics Announces Issuance of New Pure SERCA2a Activator PatentNASDAQ:WINTWindtree Therapeutics Inc
09/11/202322h15GlobeNewswire Inc.Windtree Therapeutics Reports Third Quarter 2023 Financial Results and Provides Key Business UpdatesNASDAQ:WINTWindtree Therapeutics Inc
08/11/202314h00GlobeNewswire Inc.Windtree to Present at the Sidoti Micro Cap Conference on November 16thNASDAQ:WINTWindtree Therapeutics Inc
12/10/202313h30GlobeNewswire Inc.Windtree to Present at the ThinkEquity Conference on October 19th in New York CityNASDAQ:WINTWindtree Therapeutics Inc
10/10/202313h30GlobeNewswire Inc.Windtree to Participate in the Lytham Partners Fall 2023 Investor Conference on October 17thNASDAQ:WINTWindtree Therapeutics Inc
03/10/202314h00GlobeNewswire Inc.Windtree to Present at the Dawson James Small Cap Growth Conference on October 12thNASDAQ:WINTWindtree Therapeutics Inc
28/09/202313h24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WINTWindtree Therapeutics Inc
21/09/202315h35GlobeNewswire Inc.Dawson James Securities Announces October Date for 8th Annual Small Cap Growth ConferenceNASDAQ:WINTWindtree Therapeutics Inc
06/09/202301h21Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:WINTWindtree Therapeutics Inc
30/08/202322h31Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:WINTWindtree Therapeutics Inc
23/08/202314h00GlobeNewswire Inc.Windtree Announces Issuance of Composition of Matter Patent for Dual Mechanism SERCA2a Activators by the US Patent and Trademark OfficeNASDAQ:WINTWindtree Therapeutics Inc
07/08/202322h05GlobeNewswire Inc.Windtree Therapeutics Reports Second Quarter 2023 Financial Results and Provides Key Business UpdatesNASDAQ:WINTWindtree Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:WINT

Dernières Valeurs Consultées

COIN
ETHUSD
Ethereum
EU
CS
Axa
NASDAQ
NVDA
NVIDIA
NYSE
MRK
Merck
EU
ML
Michelin
NASDAQ
GOOGL
Alphabet
EU
BEL20
Bel 20
EU
RNO
Renault
NASDAQ
AAPL
Apple
EU
EN
Bouygues
EU
BNP
BNP Paribas
EU
RI
Pernod Ricard
NASDAQ
MSFT
Microsoft
EU
VIV
Vivendi
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés